Primary Surgical Prevention of Breast Cancer-related Lymphedema
- Status
- RECRUITING
- Phase
- NA
Clinical Trials Related to Breast Cancer
Related studies linked through entity extraction aliases.
Improving Survivorship Among Minority Cancer Dyads
- Status
- WITHDRAWN
- Phase
- NA
Prognostic Value of Biomarkers in HR + / HER2 - Advanced Breast Cancer
- Status
- UNKNOWN
- Phase
- N/A
The Establishment of a Survival Prediction Model for ER Positive / HER-2 Negative Advanced Breast Cancer
- Status
- UNKNOWN
- Phase
- N/A
A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Efficacy and Safety of Eribulin in the Treatment of Advanced Breast Cancer
- Status
- UNKNOWN
- Phase
- N/A
Real-time Diagnosis and Visualization of Tumor Margins in Excised Breast Specimens Using Zenith FLIM Diagnostics
- Status
- SUSPENDED
- Phase
- NA
A Phase 1a/1b FIH Study of PY159 and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Safety of Continuing HER-2 Directed Therapy in Overt Left Ventricular Dysfunction
- Status
- RECRUITING
- Phase
- PHASE2
Single Fraction Preoperative Radiotherapy for Early Stage Breast Cancer
- Status
- RECRUITING
- Phase
- NA
A Pilot Study of Ultrasound-guided Vacuum-assisted Excision of Breast Cancers
- Status
- COMPLETED
- Phase
- N/A
Physical Activity Levels and Functional Improvement in Breast Cancer Survivors
- Status
- UNKNOWN
- Phase
- NA
A Phase II Window of Opportunity Trial of PRMT5 Inhibitor, GSK3326595, in Early Stage Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
NBP in Women With Metastatic Breast Cancer to Prevent Nab-paclitaxel Induced Toxic Neuropathy
- Status
- WITHDRAWN
- Phase
- PHASE2
HER2 Expression Detection and Radionuclide Therapy in Breast Cancer Using 99mTc/188Re Labeled Single Domain Antibody
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Prospective, Multi-site Clinical Study to Collect User Feedback Using Affirm® Contrast Biopsy
- Status
- COMPLETED
- Phase
- NA
Adaptive Training Exercise Programs for Improving Cardiorespiratory Fitness After Breast Cancer Treatment, The ACTIVATE Trial
- Status
- COMPLETED
- Phase
- NA
Effect of Endocrine Therapy Duration on Clinical Outcome of Patients With HR+ Intraductal Carcinoma of the Breast
- Status
- UNKNOWN
- Phase
- N/A